About: biopharmaceuticals

Health 26-08-2019

What European patients need: a shot of some good old Belgian surrealism

In art, Belgium is internationally recognised as the land of surrealism, where reality and dreams are intertwined to offer a new perspective on the world. Life sciences is another Belgian specialty and a major historical export product, a group of authors write.
Development Policy 21-01-2016

Ebola epidemic reveals gaps in research into diseases of poverty

The Vaccine Alliance has announced that it will fund research into an Ebola vaccine. Without public funding, laboratories often ignore illnesses that affect the poorest patients. EURACTIV France reports.

Biopharmaceuticals booming in Germany despite GMO controversy

Modern pharmaceuticals are no longer exclusively produced in a chemicals laboratory, but are often developed using live cells. In Germany, such biopharmaceuticals are being sold and prescribed at an ever increasing rate – despite widespread scepticism over GMOs in Germany. EURACTIV Germany reports.
 InfographicPromoted content
Investing in the future of health
Health 04-12-2014

Investing in the future of health

In a bid to highlight the important yet highly delicate nature of Europe’s innovative industries, a new report, produced by the Deloitte Health Economics Group and commissioned by Janssen, has sought to evaluate the comparable risks incurred across five major industries.
Health 03-12-2014

A new debate is needed for biopharmaceuticals

The increasing complexity and uncertainty of drug development is hampering the industry’s ability to discover new, life-changing innovative medicines, writes Stefan Gijssels.

Want to know what's going on in the EU Capitals daily? Subscribe now to our new 9am newsletter.